Nicotinic Acetylcholine Receptor Signaling in Neuroprotection, Softcover reprint of the original 1st ed. 2018

This open access book presents the roles and mechanisms of signal transduction triggered by nicotinic acetylcholine receptors (nAChRs) stimulation in neuroprotection against toxic effects of risk factors of neurodegenerative diseases. Accumulating evidence suggests that nAChRs in the CNS play important roles not only in excitatory neurotransmission but also in neuronal survival and related functions. Neuroprotection mediated by nAChRs in neurodegenerative diseases such as Alzheimer's disease is the major topic of this book. In response to rapidly evolving areas in clinical and laboratory neuropharmacology and neurochemistry, this volume provides in-depth coverage of neuroprotection in basic research and future developments in the clinical application of effective neuroprotective strategies in neurodegenerative diseases. This work appeals to both basic and clinical researchers in several fields, such as neuroscience, neurology, and pharmacology.

Akinori Akaike

Department of Pharmacology, Kyoto University, Japan

Shun Shimohama

Department of Neurology, Sapporo Medical University School of Medicine, Japan

Yoshimi Misu

Graduate School of Medicine, Yokohama City University, Japan

Summarizes and enriches understanding of the novel aspects of nicotinic acetylcholine receptor (nAChR) functions in the CNS

Professionals and scholars alike will find it a handy up-to-date overview of basic and clinical studies of nAChRs for the treatment of neurodegenerative diseases

This Open Access Book has an interdisciplinary appeal and will engage scholars in field of drug innovation